Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Health Diagnostics

Therapeutics

Clinical Trials

Biotechnology

Visterra Inc.

Brian J.G. Pereira

Director / Sr. Director, Regulatory Affairs

Director, Quality Systems & Compliance

David Oldach

Zachary Shriver

Jill Yarbrough

Marcia Heron

Jonathan Lonczak

Chris Kiefer

Todd Curtis

Jean Bender

The Research and Development team at Visterra Inc. focuses on the discovery and development of therapeutic and diagnostic products for infectious diseases. Leveraging their expertise in glycobiology and glycochemistry, this team conducts rigorous preclinical and clinical studies, designs innovative drug candidates, and manages research programs and alliances to advance Visterra's therapeutic pipeline. They play a crucial role in turning scientific discoveries into viable medical treatments.

Research and Development

Leadership Team

��

Research and Development

About

Team members

��������

Research and Development

About

Team members

��